This edition of Navigating Lung Cancer 360º of Hope includes updates on new FDA approved drugs, molecular testing, immunotherapy, and a Special Clinical Trials Report. Buy it at Amazon, gift it, or download a free PDF.
This publication includes updates on new FDA approved drugs, molecular testing, immunotherapy, reimbursement and more, and entirely new with V.2 is a Special Clinical Trials Report. In keeping with our commitment to make the PEH available to diverse populations, V.2 will soon be available in Chinese, with plans for a Spanish version now in the works.
Released for the first time through ALCF, the Special Clinical Trials Report is written in patient-friendly, easy-to-understand language by Ross Camidge, MD, PhD, University of Colorado, a leading lung cancer clinician. It will help patients and caregivers to understand: how clinical trials work; their importance to discovery and patient treatment; how trial participation benefits each individual patient as well as others; etc.
CALL TO ACTION: Help someone navigate lung cancer with hope and critical information.